[{"id":"9e72d219-f74b-4c5d-ba34-f05984c3935d","acronym":"","url":"https://clinicaltrials.gov/study/NCT03958656","created_at":"2021-09-09T17:53:47.480Z","updated_at":"2024-07-02T16:36:24.633Z","phase":"Phase 1","brief_title":"T-cells Expressing an Anti-SLAMF7 CAR for Treating Multiple Myeloma","source_id_and_acronym":"NCT03958656","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" SLAMF7","pipe":"","alterations":" ","tags":["SLAMF7"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fludarabine IV • Anti-SLAMF7 CAR T cells • rimiducid (AP1903)"],"overall_status":"Completed","enrollment":" Enrollment 13","initiation":"Initiation: 06/13/2019","start_date":" 06/13/2019","primary_txt":" Primary completion: 10/13/2020","primary_completion_date":" 10/13/2020","study_txt":" Completion: 01/19/2021","study_completion_date":" 01/19/2021","last_update_posted":"2021-09-09"}]